US2009148925A1PendingUtilityA1
Single chain class I major histocompatibility complexes
Assignee: TECHNION RES & DEV FOUNDATIONPriority: Mar 27, 2000Filed: Jun 18, 2008Published: Jun 11, 2009
Est. expiryMar 27, 2020(expired)· nominal 20-yr term from priority
Inventors:Yoram Reiter
C07K 14/70539
66
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A recombinant polypeptide and nucleic acid constructs capable of expressing the recombinant polypeptide are provided. The recombinant polypeptide comprises a chimeric polypeptide including an antigenic peptide being capable of binding a human MHC class I, a functional human β-2 microglobulin and a functional human MHC class I heavy chain.
Claims
exact text as granted — not AI-modified1 - 11 . (canceled)
12 . A nucleic acid construct comprising a first nucleic acid sequence encoding an antigenic peptide capable of binding a mammalian MHC class I, and a second nucleic acid sequence encoding a mammalian beta-2 microglobulin translationally fused upstream of a functional mammalian MHC class I heavy chain.
13 . The nucleic acid construct of claim 12 , wherein said first nucleic acid sequence and said second nucleic acid sequence are translationally fused.
14 . The nucleic acid construct of claim 13 , wherein said first nucleic acid sequence is translationally fused upstream of said second nucleic acid sequence.
15 . A bacterial cell transformed with a nucleic acid construct which comprises a first nucleic acid sequence encoding an antigenic peptide capable of binding a mammalian MHC class I, and a second nucleic acid sequence encoding a mammalian beta-2 microglobulin translationally fused upstream of a functional mammalian MHC class I heavy chain.
16 . The bacterial cell of claim 15 , wherein said first nucleic acid sequence and said second nucleic acid sequence are translationally fused.
17 . The bacterial cell of claim 15 , wherein said first nucleic acid sequence is translationally fused upstream of said second nucleic acid sequence.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.